Articles

Eli Lilly Forced To Remove Restrictions

Eli Lilly is exempting Arkansas from its new 340B contract pharmacy restrictions due to Arkansas state law.

The decision, communicated in a November 13 letter, means the stricter rules won't apply to Arkansas entities, citing the state's Act 1103. It's unclear if similar exemptions will extend to Louisiana. Lilly's initial November 6 notice restricted 340B-priced product distribution but allowed exceptions. The recent letter ensures Arkansas follows Lilly's existing contract pharmacy policy, contingent on legal rulings on Act 1103's constitutionality, currently under challenge in the 8th U.S. Circuit Court of Appeals.

Source: 340B Report

 

The 340B Drug Pricing Program is managed by the Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA). For more information visit: www.hrsa.gov/opa This material is provided for general informational purposes of 340B Drug Prices only and is not an endorsement of any prescription product referenced herein. For information as to the clinical use or efficacy of a referenced product, please contact the manufacturer. 340B Price Guide makes no representations and provides no warranties as to the effectiveness or suitability for use of any prescription product referenced herein. Any referenced cost is provided as an estimate only and the actual cost is subject to change at any time and without notice. 340B Price Guide does not guarantee that the cost represented herein will be the actual and pharmacy shall at all times collect amounts due as indicated at the time of adjudication and shall be reimbursed per the terms of its agreement.'